Name :
*
Company Name :
E-mail :
*
Additional Information :


G.Cyte

Recombinant human granulocyte colony stimulating factor

  • A significant aid to eradicate Neutropenia

COMPOSITION
One 0.9 ml Pre filled syringe of G.CYTE contains Filgrastim 300 mcg.

Indications
Cancer Patients Receiving Myelosuppressive Chemotherapy
G.CYTE decreases the incidence of infection, as manifested by febrile neutropenia, in patients with non-myeloid malignancies receiving myelosuppressive anticancer drugs associated with a significant incidence of severe neutropenia fever.

Patients with Acute Myeloid Leukemia Receiving Induction or Consolidation Chemotherapy
G.CYTE reduces the time to neutrophil recovery and the duration of fever.

Cancer Patients Receiving Bone Marrow Transplantation
G.CYTE reduces the duration of neutropenia and neutropenia –related clinical squeal e.g. Febrile neutropenia, in patients with non- myeloid malignances undergoing myeloablative chemotherapy followed by marrow transplantation.

Patients Undergoing Peripheral Blood Progenitor Cell Collection and therapy
G.CYTE mobilizes hematopoietic progenitor cells into the peripheral blood for collection by leukapheresis